Researchers sought to assess the impact of smoking habits, exposure to passive smoking, and snuff use on disease progression, cognitive performance, and quality of life in patients with MS.
Tascenso ODT is a sphingosine 1-phosphate receptor modulator.
In a large case-control study, researchers assessed the effect of sleep duration, circadian disruption, and sleep quality on MS risk.
Researchers sought to examine potential associations between viral exposures and neurodegenerative disease risk.
The CD20-directed cytolytic antibody therapy was approved based on data from two phase 3 trials.
Researchers sought to explore the relationship between the initiation of MS treatment and patient-reported symptoms and health-related quality of life.
Researchers sought to evaluate the effect of long-term exposure to PM2.5, PM10, and NO2 on the severity of COVID-19 among patients with MS.
Research findings support the use of vitamin D supplementation to help slow cognitive decline in Alzheimer dementia and reduce Parkinson disease symptom severity.
The application is under review for relapsing forms of multiple sclerosis and Crohn disease.
Researchers sought to determine the efficacy of a lavender capsule on reducing fatigue symptoms in patients with MS.
